• Longitudinal Study of the Variation in Patient Turnover and Patient-to-Nurse Ratio: Descriptive Analysis of a Swiss University Hospital 

      Musy S.N., Endrich O., Leichtle A.B., Griffiths P., Nakas C.T., Simon M. (2020)
      Background: Variations in patient demand increase the challenge of balancing high-quality nursing skill mixes against budgetary constraints. Developing staffing guidelines that allow high-quality care at minimal cost ...
    • Longitudinal Trajectories and Normative Language Standards in Older Adults With Normal Cognitive Status 

      Folia V., Liampas I., Ntanasi E., Yannakoulia M., Sakka P., Hadjigeorgiou G., Scarmeas N., Dardiotis E., Kosmidis M.H. (2022)
      Objective: To determine the longitudinal trajectories and normative standards of language in older adults. Method: Participants were drawn from the cognitively normal (CN) subgroup of the Hellenic Longitudinal Investigation ...
    • Longterm beneficial effect of canakinumab in colchicine-resistant familial mediterranean fever 

      Laskari K., Boura P., Dalekos G.N., Garyfallos A., Karokis D., Pikazis D., Settas L., Skarantavos G., Tsitsami E., Sfikakis P.P. (2017)
      Objective. To assess the efficacy and safety of the interleukin-1β (IL-1β) inhibitor canakinumab in all adolescent and adult patients with familial Mediterranean fever (FMF) identified from the Greek National Registry for ...
    • Malnutrition in older adults: Correlations with social, diet-related, and neuropsychological factors 

      Katsas K., Mamalaki E., Kontogianni M.D., Anastasiou C.A., Kosmidis M.H., Varlamis I., Hadjigeorgiou G.M., Dardiotis E., Sakka P., Scarmeas N., Yannakoulia M. (2020)
      BACKGROUND: The number of older adults is increasing rapidly. Malnutrition is a major problem in this age group, which may adversely affect health and quality of life. Several physiological, socioeconomic, and neuropsychological ...
    • Mechanical Low Back Pain in Elite Track and Field Athletes: An observational cohort study 

      Malliaropoulos N., Bikos G., Meke M., Tsifountoudis I., Pyne D., Korakakis V. (2017)
      OBJECTIVE: The aim of the study was to gain information about the incidence of mechanical Low Back Pain (MLBP) injuries etiology in elite track and field athletes and to assess the recurrence rate. BACKGROUND: The prevalence ...
    • Mediterranean diet adherence is related to reduced probability of prodromal Parkinson's disease 

      Maraki M.I., Yannakoulia M., Stamelou M., Stefanis L., Xiromerisiou G., Kosmidis M.H., Dardiotis E., Hadjigeorgiou G.M., Sakka P., Anastasiou C.A., Simopoulou E., Scarmeas N. (2019)
      Background: The International Parkinson and Movement Disorder Society recently introduced a methodology for probability score calculation for prodromal PD. Objectives: To assess the probability of prodromal PD in an older ...
    • Mediterranean diet and cognitive health: Initial results from the Hellenic Longitudinal Investigation of Ageing and Diet 

      Anastasiou C.A., Yannakoulia M., Kosmidis M.H., Dardiotis E., Hadjigeorgiou G.M., Sakka P., Arampatzi X., Bougea A., Labropoulos I., Scarmeas N. (2017)
      Background: The Mediterranean dietary pattern has been associated with a decreased risk of many degenerative diseases and cognitive function in particular; however, relevant information from Mediterranean regions, where ...
    • Mediterranean diet and risk for dementia and cognitive decline in a Mediterranean population 

      Charisis S., Ntanasi E., Yannakoulia M., Anastasiou C.A., Kosmidis M.H., Dardiotis E., Hadjigeorgiou G., Sakka P., Scarmeas N. (2021)
      Background: Current evidence suggests that nutrition in general and specific dietary patterns in particular, such as the Mediterranean type diet (MeDi), can be employed as potential preventive strategies against the ...
    • Motor and Nonmotor Features of Carriers of the p.A53T Alpha-Synuclein Mutation: A Longitudinal Study 

      Papadimitriou D., Antonelou R., Miligkos M., Maniati M., Papagiannakis N., Bostantjopoulou S., Leonardos A., Koros C., Simitsi A., Papageorgiou S.G., Kapaki E., Alcalay R.N., Papadimitriou A., Athanassiadou A., Stamelou M., Stefanis L. (2016)
      Background: G209A SNCA mutation carriers represent an important group of genetic PD. We describe motor and nonmotor features of G209A SNCA mutation carriers. Methods: Longitudinal clinical assessments over 2 years were ...
    • Motor function and the probability of prodromal Parkinson's disease in older adults 

      Maraki M.I., Stefanis L., Yannakoulia M., Kosmidis M.H., Xiromerisiou G., Dardiotis E., Hadjigeorgiou G.M., Sakka P., Scarmeas N., Stamelou M. (2019)
      Background: Identification and characterization of Parkinson's disease (PD) in its prodromal stage is crucial. Objective: The objective of this study was to investigate the association between motor function and the ...
    • Objective and Subjective Measurements of Motor Function: Results from the HELIAD Study 

      Kalligerou F., Paraskevas G., Zalonis I., Kosmidis M.H., Yannakoulia M., Dardiotis E., Hadjigeorgiou G., Sakka P., Scarmeas N. (2022)
      Background: Slow gait speed has recently emerged as a potential prodromal feature of cognitive decline and dementia. Besides objective measurements, subjective motor function (SMF) difficulties might be present prior to ...
    • Outcome of refractory to conventional and/or biologic treatment adult Still's disease following canakinumab treatment: Countrywide data in 50 patients 

      Laskari K., Tektonidou P.M.G., Katsiari P.C., Athanassiou P., Dimopoulou D., Gerodimos C., Salamaliki C., Papagoras P.C., Settas P.L., Vassilopoulos P.D., Voulgari P.P.V., Zakalka M., Georgiadis A., Gkoni G., Daoussis P.D., Dimitroulas P.T., Iliou C., Kallitsakis I., Grika E.P., Mavragani P.C., Pikazis P.D., Raftakis J., Sarikoudis T., Kougkas N., Soukera D., Theodorou E., Tsatsani P., Tsiakou E., Vlachoyiannopoulos P.P., Vosvotekas G., Sfikakis P.P.P. (2021)
      Objective: To assess the efficacy and safety of the IL-1b inhibitor canakinumab in all adults with refractory Still's disease identified from the National Organization For Medicines for off-label drug use. Methods
    • Pesticide exposure and cognitive function: Results from the Hellenic Longitudinal Investigation of Aging and Diet (HELIAD) 

      Dardiotis E., Siokas V., Moza S., Kosmidis M.H., Vogiatzi C., Aloizou A.-M., Geronikola N., Ntanasi E., Zalonis I., Yannakoulia M., Scarmeas N., Hadjigeorgiou G.M. (2019)
      Background: Results from studies to date, regarding the role of chronic pesticide exposure on cognitive function remain contradictory. Objective: To investigate the relationship between self-reported pesticide exposure and ...
    • Plasma Glutathione and Prodromal Parkinson's Disease Probability 

      Charisis S., Ntanasi E., Stamelou M., Xiromerisiou G., Maraki M., Veskoukis A.S., Yannakoulia M., Kosmidis M.H., Anastasiou C.A., Giagkou N., Dardiotis E., Hadjigeorgiou G., Sakka P., Kouretas D., Stefanis L., Scarmeas N. (2022)
      Background: A decrease in glutathione (GSH) levels is considered one of the earliest biochemical changes in Parkinson's disease (PD). Objective: The authors explored the potential role of plasma GSH as a risk/susceptibility ...
    • Plasma GSH levels and Alzheimer's disease. A prospective approach.: Results from the HELIAD study 

      Charisis S., Ntanasi E., Yannakoulia M., Anastasiou C.A., Kosmidis M.H., Dardiotis E., Hadjigeorgiou G., Sakka P., Veskoukis A.S., Kouretas D., Scarmeas N. (2021)
      Background: Potential links between oxidative stress and the pathophysiology of Alzheimer's disease (AD) have been reported in the existing literature. Biological markers of oxidative stress, such as the reduced form of ...
    • Politicization of COVID-19 health-protective behaviors in the United States: Longitudinal and cross-national evidence 

      Stroebe W., vanDellen M.R., Abakoumkin G., Lemay E.P., Jr., Schiavone W.M., Agostini M., Bélanger J.J., Gützkow B., Kreienkamp J., Reitsema A.M., Abdul Khaiyom J.H., Ahmedi V., Akkas H., Almenara C.A., Atta M., Bagci S.C., Basel S., Kida E.B., Bernardo A.B.I., Buttrick N.R., Chobthamkit P., Choi H.-S., Cristea M., Csaba S., Damnjanović K., Danyliuk I., Dash A., Di Santo D., Douglas K.M., Enea V., Faller D.G., Fitzsimons G., Gheorghiu A., Gómez Á., Hamaidia A., Han Q., Helmy M., Hudiyana J., Jeronimus B.F., Jiang D.-Y., Jovanović V., Kamenov Ž., Kende A., Keng S.-L., Kieu T.T.T., Koc Y., Kovyazina K., Kozytska I., Krause J., Kruglanksi A.W., Kurapov A., Kutlaca M., Lantos N.A., Jaya Lemsmana C.B., Louis W.R., Lueders A., Malik N.I., Martinez A., McCabe K.O., Mehulić J., Milla M.N., Mohammed I., Molinario E., Moyano M., Mula S., Muluk H., Myroniuk S., Najafi R., Nisa C.F., Nyúl B., O’Keefe P.A., Olivas Osuna J.J., Osin E.N., Park J., Pica G., Pierro A., Rees J., Resta E., Rullo M., Ryan M.K., Samekin A., Santtila P., Sasin E., Schumpe B.M., Selim H.A., Stanton M.V., Sultana S., Sutton R.M., Tseliou E., Utsugi A., van Breen J.A., van Lissa C.J., van Veen K., Vázquez A., Wollast R., Yeung V.W.-L., Zand S., Žeželj I.L., Zheng B., Zick A., Zúñiga C., Pontus Leander N., Muhammad H. (2021)
      During the initial phase of the COVID-19 pandemic, U.S. conservative politicians and the media downplayed the risk of both contracting COVID-19 and the effectiveness of recommended health behaviors. Health behavior theories ...
    • Predictors of adherence to public health behaviors for fighting COVID-19 derived from longitudinal data 

      Schumpe B.M., Van Lissa C.J., Bélanger J.J., Ruggeri K., Mierau J., Nisa C.F., Molinario E., Gelfand M.J., Stroebe W., Agostini M., Gützkow B., Jeronimus B.F., Kreienkamp J., Kutlaca M., Lemay E.P., Jr, Reitsema A.M., vanDellen M.R., Abakoumkin G., Abdul Khaiyom J.H., Ahmedi V., Akkas H., Almenara C.A., Atta M., Bagci S.C., Basel S., Berisha Kida E., Bernardo A.B.I., Buttrick N.R., Chobthamkit P., Choi H.-S., Cristea M., Csaba S., Damnjanović K., Danyliuk I., Dash A., Di Santo D., Douglas K.M., Enea V., Faller D., Fitzsimons G.J., Gheorghiu A., Gómez Á., Hamaidia A., Han Q., Helmy M., Hudiyana J., Jiang D.-Y., Jovanović V., Kamenov Z., Kende A., Keng S.-L., Kieu T.T.T., Koc Y., Kovyazina K., Kozytska I., Krause J., Kruglanski A.W., Kurapov A., Lantos N.A., Lesmana C.B.J., Louis W.R., Lueders A., Malik N.I., Martinez A.P., McCabe K.O., Mehulić J., Milla M.N., Mohammed I., Moyano M., Muhammad H., Mula S., Muluk H., Myroniuk S., Najafi R., Nyúl B., O’Keefe P.A., Olivas Osuna J.J., Osin E.N., Park J., Pica G., Pierro A., Rees J.H., Resta E., Rullo M., Ryan M.K., Samekin A., Santtila P., Sasin E., Selim H.A., Stanton M.V., Sultana S., Sutton R.M., Tseliou E., Utsugi A., van Breen J.A., Van Veen K., Vázquez A., Wollast R., Yeung V.W.-L., Zand S., Žeželj I.L., Zheng B., Zick A., Zúñiga C., Leander N.P. (2022)
      The present paper examines longitudinally how subjective perceptions about COVID-19, one’s community, and the government predict adherence to public health measures to reduce the spread of the virus. Using an international ...
    • Prognostic assessment in COPD without lung function: The B-AE-D indices 

      Boeck L., Soriano J.B., Brusse-Keizer M., Blasi F., Kostikas K., Boersma W., Milenkovic B., Louis R., Lacoma A., Djamin R., Aerts J., Torres A., Rohde G., Welte T., Martinez-Camblor P., Rakic J., Scherr A., Koller M., Van Der Palen J., Marin J.M., Alfageme I., Almagro P., Casanova C., Esteban C., Soler-Cataluña J.J., De-Torres J.P., Miravitlles M., Celli B.R., Tamm M., Stolz D. (2016)
      Several composite markers have been proposed for risk assessment in chronic obstructive pulmonary disease (COPD). However, choice of parameters and score complexity restrict clinical applicability. Our aim was to provide ...
    • Real-world clinical outcomes of treatment with brodalumab in patients with moderate-to-severe psoriasis: a retrospective, 24-month experience from four academic dermatology centers in Greece 

      Papadavid E., Zafeiriou E., Georgiou S., Roussaki-Schulze A.-V., Spiliopoulos T., Vryzaki E., Oikonomou C., Drongoula O., Boziou M., Goudouras G., Sfaelos K., Apalla Z., Lazaridou E. (2022)
      Objective: To assess the real-world clinical treatment outcomes with brodalumab in patients with moderate-to-severe plaque psoriasis in Greece. Materials and methods: This was a longitudinal, retrospective, real-world ...